Vaxart Inc
(VXRT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2001 | 06-2001 | 12-2000 | 06-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 104,682 | 0 | 4,359 | 0 | 3,344 |
| Depreciation Amortization | 9,491 | 5,300 | 9,838 | 5,030 | 10,128 |
| Income taxes - deferred | 4,258 | 0 | N/A | 0 | N/A |
| Accounts receivable | 1,648 | 0 | -4,676 | 0 | 6,146 |
| Other Working Capital | 4,428 | 4,640 | -3,295 | -3,650 | 9,512 |
| Other Operating Activity | -100,456 | 3,030 | 3,585 | 360 | -5,866 |
| Operating Cash Flow | $24,051 | $12,970 | $9,811 | $1,740 | $23,264 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 139,130 | -8,400 | -18,983 | -9,660 | -18,518 |
| Purchase Sale Intangibles | -3,387 | 0 | -1,809 | 0 | N/A |
| Other Investing Activity | -3,387 | -190 | -1,809 | 0 | 0 |
| Investing Cash Flow | $135,743 | $-8,590 | $-20,792 | $-9,660 | $-18,518 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -31,035 | 0 | -1,463 | 0 | -5,045 |
| Common Stock Issued | 1,856 | 0 | 13,192 | 0 | 89 |
| Common Stock Repurchased | -977 | 0 | N/A | 0 | N/A |
| Other Financing Activity | 0 | -130 | 0 | 3,000 | 0 |
| Financing Cash Flow | $-30,156 | $-130 | $11,729 | $3,000 | $-4,956 |
| Beginning Cash Position | 1,554 | 0 | 806 | 0 | 1,016 |
| End Cash Position | 131,192 | 0 | 1,554 | 0 | 806 |
| Net Cash Flow | $129,638 | $4,250 | $748 | $-4,920 | $-210 |
| Free Cash Flow | |||||
| Operating Cash Flow | 24,051 | 12,970 | 9,811 | 1,740 | 23,264 |
| Capital Expenditure | -13,052 | 0 | -18,983 | 0 | -21,036 |
| Free Cash Flow | 10,999 | 12,970 | -9,172 | 1,740 | 2,228 |